DONNA CAGLE: Open Payments
NPI 1205978194 · MISSION HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 9 payments from 5 companies in 2025. Trend: 2023 $46 · 2024 $78 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| Mayne Pharma Commercial LLC | 3 | $260 |
| MILLICENT US INC | 2 | $41 |
| Organon LLC | 2 | $35 |
| Astellas Pharma US Inc | 1 | $33 |
| Sage Therapeutics, LLC | 1 | $31 |
Products named: ANNOVERA, BIJUVA, NEXPLANON, Veozah, ZURZUVAE, INTRAROSA, FEMLYV.
Industry payments across CA — which companies pay providers there.
